Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,984,012
-
Share change
-
+1,367,608
-
Total reported value
-
$148,590,071
-
Price per share
-
$7.82
-
Number of holders
-
60
-
Value change
-
+$6,661,039
-
Number of buys
-
35
-
Number of sells
-
21
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q1 2017
As of 31 Mar 2017,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,984,012 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, NEA Management Company, LLC, FMR LLC, JENNISON ASSOCIATES LLC, PRICE T ROWE ASSOCIATES INC /MD/, Hillhouse Capital Management, Ltd., Marshall Wace North America L.P., FIL Ltd, VANGUARD GROUP INC, and Rock Springs Capital Management LP.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.